Bart Van der Schueren, PhD

Bart Van der Schueren in an associate professor in Endocrinology at the University of Leuven, Belgium. He obtained his medical degree from the same University in 2002. In 2009 he successfully defended his PhD on the topic of drug development for migraine treatment. The emphasis of this work was on developing techniques to assess cardiovascular effects of new drugs early in their clinical development. In the same year he was recognized as a Clinical Pharmacologist by the Dutch Society of Clinical Pharmacology and Biopharmacy. Following his PhD, he finished his internship and graduated in 2010 as a Specialist in Internal Medicine and Endocrinology. Subsequently, he left for a post-doctoral scholarship at Columbia University College of Physicians and Surgeons, New York, USA to study the hormonal and metabolic effect of bariatric surgery. He returned to Belgium in September 2011 and is now responsible for the obesity and lipid clinic at the University Hospital in Leuven. He is teaching endocrinology and clinical trial management at the faculty of Medicine at the University of Leuven. He was the Belgian member of the committee for medicinal products for human use  (CHMP) and a member of the cardiovascular working party (CVWP) at the European Medicines Agency (EMA) from 2011 until July 2020. He is the president elect of the Belgian Association for the Study of Obesity (BASO) since 2018.